RNA-LNP
-
M2004 DMG-PEG2000-NHSSummary: NHS-PEG derivatives, used for liposomal delivery -
M2002 DSG-PEG 2000Summary: PEG modified phospholipids for liposome delivery -
M2001 DMG-PEG 20001 CitationSummary: PEG modified phospholipids for liposome delivery -
C4911 1,2-Distearoyl-sn-glycero-3-PCSummary: Liposomes assist phospholipids -
C4855 1,2-Distearoyl-sn-glycero-3-PESummary: Liposomes assist phospholipids -
C4002 1,2-Dipalmitoyl-sn-glycero-3-PCSummary: Liposomes assist phospholipids -
C1042 SM-1024 Citation -
B8596 ALC-0159Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines. -
B8595 ALC-0315Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines. -
B1702 Cholesterol2 CitationSummary: The principal sterol to build and maintain membranes
